Calendar | For Your Patients | PHA Main Site | Contact Us | About Us | Not a registered user? Sign up here.

Courses Quicksearch

Search Now!

Courses

Updated Algorithm of PAH Treatment: Phrontline News

Mardi Gomberg-Maitland


Reviews

  Sign in to add a review

0 comments
Leave a Comment

Course ID: 2818

CEU Information

Description

This course will discuss the current treatment algorithm based on guideline consensus. The new guidelines include the recently reported Phase 3 studies of macitentan, riociguat, and selexipeg. The session will cover general measures of care, and discuss monotherapy and combination therapy evidence-based data. The session will conclude with a discussion of remaining gaps in clinical care that need further evidence.

Course Authors

Mardi Gomberg-Maitland, M.D., MSC
University of Chicago Medical Center
Chicago, Ill.

Course Reviewer

George J. Vuturo, Ph.D., RPh
CME/CE Director
Chief Compliance Officer
Planning Committee Member
Professional Education Services Group, LLC, Sterling, VA

Content Reviewer

Janice Agazio, Ph.D., CRNP, RN, FAANP, FAAN
Lead Nurse Planner Planning Committee Member Professional Education Services Group, LLC,
Sterling, VA Assistant Dean for Doctoral Programs and Ordinary Professor School
of Nursing the Catholic University of America, Washington, DC

CME Reviewer

Danielle Spencer
CME/CE Project Director
Professional Education Services Group, LLC, Sterling, VA

Intended Audience

This continuing education activity provides continuing education (CE) credits for:

  1. Physicians
  2. Nurses
  3. Pharmacists and Pharmacy Technicians
  4. Respiratory Therapists
  5. Social Workers
  6. Other Related Health Professionals

Learning Objectives

At the conclusion of this activity participants should be able to:

  • Review both general therapeutic and health maintenance measures of care
  • Understand the evidence-based data of current therapeutics for PAH
  • Understand the gaps in clinical care knowledge pertaining to these guidelines

Release Date

8 March 2017

Expiration Date

31 December 2017

Estimated Time to Complete This Activity

30 minutes

Accreditation Statement

 Nurses

Professional Education Services Group is an accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides a maximum of 0.5 contact hours of nurse CE credit.

 Pharmacists and Pharmacy Technicians

Professional Education Services Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE UAN 0829-0000-16-189-L04 (Pharmacists) and 0829-0000-16-189-L04 (Pharmacy Technicians). This activity provides 0.5 contact hours (0.10 CEUs) of continuing education credit. There is no cost for this activity. Your record of completion will be reported directly to the CPE Monitor.

 Respiratory Therapists

The Continuing Respiratory Education (CRCE) system of the American Association for Respiratory Care (AARC) grants approval for 0.5 hours for this course.

 Social Workers

This program is approved by the National Association of Social Workers for 0.5 Social Work continuing education contact hour.

Instructions for Earning Credit

This activity is a self-study program. In order to claim CE credit, participants must:

  1. View the content, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be directed to the CE processing center at http://pha.cds.pesgce.com and claim CE credit.
  2. Complete a post-test and evaluation online. All evaluation questions must be completed in order to receive a CE credit.
  3. Upon successful completion of the post-test and online evaluation form, you can instantly download and/or print your certificate of credit. Your CE records will be stored at http://pha.cds.pesgce.com for later retrieval at your convenience.

CE Inquiries

For all CE related inquiries, please contact Support@PESGCE.com or PHA Online University at (301)-565-3004-x771.

Disclosure Policy

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Professional Educational Services Group (PESG) to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty and planners of this educational activity disclose the following:


Mardi Gomberg-Maitland, M.D., MSC, discloses the following;
Gilead Sciences, Inc.-Consultant, U of Chicago Research Grant; Actelion Pharmaceuticals US, Inc.- Consultant, U of Chicago Research Grant; Medtronic-Consultant, U of Chicago Research Grant; Lung Biotechnology-U of Chicago Research Grant; Novartis-U of Chicago Received Research Grant; Reata- Consultant, U of Chicago Research Grant; Bayer HealthCare-Consultant, U of Chicago Research Grant; Bellerophon-Consultant; United Therapeutics Corporation-Consultant; GeNO- Consultant; PCORI Rare Disease Advisory Panel Member

Disclaimer

The information presented in this activity reflects the views of the faculty only and not necessarily those of the Pulmonary Hypertension Association (PHA), the sponsors or the educational grant providers. All participants should verify the information and data presented before treating patients or utilizing any therapies noted in these materials. No portion of this activity may be reproduced without the expressed written consent of PHA.

Technical Requirements

This course requires an internet browser. For optimum display, please use Mozilla Firefox, Safari or Google Chrome.

Privacy Policy

For information about PHA's privacy policy, visit http://www.PHAssociation.org/PrivacyPolicy.

This activity is made possible through unrestricted educational grants to the PHA Medical Education Fund from Actelion Pharmaceuticals, US; Gilead Sciences, Bayer HealthCare, and United Therapeutics.

©2016 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.